0000899243-18-031732.txt : 20181226 0000899243-18-031732.hdr.sgml : 20181226 20181226185804 ACCESSION NUMBER: 0000899243-18-031732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181222 FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ray Nitya G. CENTRAL INDEX KEY: 0001709522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 181253481 MAIL ADDRESS: STREET 1: 14 BAYBURY COURT CITY: EAST HANOVER STATE: NJ ZIP: 07936 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-22 0 0001175680 CytoDyn Inc. CYDY 0001709522 Ray Nitya G. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 See Remarks Stock Options (right to buy) 0.48 2018-12-22 4 A 0 400000 0.00 A 2028-12-22 Common Stock 400000 400000 D The options vest in three equal annual installments commencing on November 16, 2019. Chief Technology Officer Head of Process Sciences, Manufacturing and Supply Chain /s/ Michael D. Mulholland, as attorney-in-fact 2018-12-26